The independent source for health policy research, polling, and news.
161 - 180 of 490 Results
Dr. Mai Pham left her corporate career to spark change in a system that is failing millions of Americans with autism and other intellectual and developmental disabilities.
As omicron sweeps the country, many hospitals are dealing with a flood of people hospitalized with covid — including those primarily admitted for other reasons. While often milder cases, so-called incidental covid infections still drain the beleaguered health care workforce and can put them and other patients at higher risk for contracting covid.
In the Nov. 8 general election, California voters will consider overturning the state’s flavored tobacco ban and hiking medical malpractice awards. Other proposals to decriminalize psychedelic mushrooms, target dialysis clinics and boost public health funding could also be on the ballot, along with a plan to limit business and school closures during public health emergencies.
The American Medical Association and American Hospital Association are not arguing to halt the law that protects patients from unexpected bills from providers they didn’t know were outside their insurance network. Instead, they want to change the rules for the mediators who will settle the dispute between insurers and providers.
The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologists’ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.
Medicare billing codes for audio-only follow-up check-ins lead to new reimbursement battles.
Physician assistants are pushing to be renamed “physician associates,” complaining their title is belittling and doesn’t convey what they do. “We don’t assist,” they insist. Doctors’ groups fear there’s more than just a name in play.
Congress last year shielded consumers from unexpected out-of-network charges, but hospitals and doctors have decried the arbitration plan put forward by the Biden administration for negotiating these bills as favoring insurers. More than 150 members of the House agree.
Hospitals and doctors are facing more demands for ivermectin as a covid-19 treatment, despite a lack of proof it works. In some Republican-dominated states, pushing for ivermectin interventions has become a conservative rallying cry.
In light of the pandemic’s shocking death toll among seniors, organizations are trying new strategies to help older Americans get better care.
Some doctors, sick of mainstream health care’s red tape, are finding refuge in practices that combine concierge medicine with charity care.
New, often lower-cost plans capitalize on the convenience of telemedicine — and patients’ growing familiarity with it. But consumers should weigh costs and care options before enrolling in a “virtual-first” plan.
Long-term relationships between patients and doctors often enrich the quality of care and create deep emotional bonds. When the doctors retire or move on, saying goodbye can be hard.
Patients are caught in the middle as insurers clamp down on paying for treatments or force prior authorizations for care.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Dr. Kingsley R. Chin and SpineFrontier were the subject of a recent KHN “Spinal Tap” investigation.
Televisits took off during the worst days of the pandemic, but states are now rolling back the temporary rules that facilitated them. That’s adding fuel to debates about states’ authority over medical licensing.
Abigail Matos-Pagán, a critical care expert who has galvanized relief efforts after hurricanes and earthquakes, is on a mission to inoculate as many Puerto Rican residents as possible.
Leaders of a regional medical school program in Montana say two proposed medical schools could create a flood of students they worry will strain the clinical faculty and resources in the state they use for training.
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
© 2026 KFF